Preclinical assessment of dual CYP26[A1/B1] inhibitor, DX308, as an improved treatment for keratinization disorders

Abstract Background Retinoid‐based therapies are commonly used in the treatment of disorders of keratinization and other skin disorders but can result in non‐specific effects and adverse reactions. Use of retinoic acid metabolism blocking agents (RAMBAs) such as DX308 may address these shortcomings....

Full description

Saved in:
Bibliographic Details
Main Authors: J.G.S. Veit (Author), Y. Poumay (Author), D. Mendes (Author), J. Kreitinger (Author), L. Walker (Author), A. Paquet (Author), C. Menigot (Author), F. Zolezzi (Author), A.S. Paller (Author), P. Diaz (Author)
Format: Book
Published: Wiley, 2021-06-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available